LEADING A TRANSFORMATION IN NEURAL
REGENERATION AND REPAIR THROUGH GENE THERAPY

ABOUT NEUEXCELL

NeuExcell Therapeutics is a gene therapy company focusing on neurodegenerative diseases. Our vision is to restore health and improve the quality of life for millions of patients worldwide suffering from neurodegenerative diseases and CNS injuries. NeuExcell’s foundation is based on Professor Gong Chen’s scientific discovery of in vivo astrocyte-to-neuron (AtN) conversion using gene therapy.  NeuExcell’s disruptive AtN technology has the potential to regenerate neuronal tissue in a damaged area caused by a wide variety of neurodegenerative conditions such as Stroke, Huntington's disease, Amyotrophic Lateral Sclerosis (ALS), Alzheimer's Disease, Parkinson's Disease, Traumatic Brain Injury, Spinal Cord Injury, Ophthalmic Diseases and Glioma.

Learn more
World Leading In Situ Neuroregeneration Technology

CORE TECHNOLOGY

World Leading In Situ Neuroregeneration Technology

NeuExcell's core technology achieves the therapeutic effect of neuroregeneration and repair through in situ astrocyte to neuron (AtN) conversion.

NeuExcell's in situ neuroregeneration technology platform, which uses endogenous glial cells to regenerate neurons in vivo, is suitable for the treatment of many major neurological diseases, including stroke, Huntington's disease, ALS, Alzheimer's disease, Parkinson's disease, traumatic brain injury, spinal cord injury, epilepsy, Ophthalmic diseases, and glioma.

OUR TEAM

Russ Addis, PhD

Russ Addis, PhD

Vice President, Research, US
Gong Chen, PhD

Gong Chen, PhD

Co-founder | Chief Scientific Advisor | Board Director
Yuchen Chen, PhD

Yuchen Chen, PhD

Vice President, R&D, China
Lori Gavrin, PhD

Lori Gavrin, PhD

Chief Business and Strategy Officer
Xin Huang, PhD

Xin Huang, PhD

Board Director
J. David Jacobs, JD

J. David Jacobs, JD

General Counsel | Senior Vice President
Ronald HW Lorijn, MD, PhD, MBA

Ronald HW Lorijn, MD, PhD, MBA

Co-Chief Executive Officer | Board Director
Jian Sheng, MD, PhD

Jian Sheng, MD, PhD

Co-Chief Executive Officer
Jonathan Sun

Jonathan Sun

Board Director
Peter Tombros, MBA

Peter Tombros, MBA

Board Director
Xi Qin. MBA

Xi Qin. MBA

Group Chief Financial Officer | Chief Operating Officer | Board Director
Jie Xu

Jie Xu

Co-Founder | Head of Discovery
Josephine Yang

Josephine Yang

Chief Financial Officer, China
Quinn Yao, PhD

Quinn Yao, PhD

Vice President, CMC
Xudong Yin, PhD, MBA

Xudong Yin, PhD, MBA

Board Chair
Dr. Gong Chen

Dr. Gong Chen

Founder | Chief Scientific Advisor

“ NeuExcell has assembled a strong and experienced leadership team. Each team member brings decades of experience in gene therapy, neuroscience, biotech and pharma industry.  The team is leading NeuExcell to drive the technology to clinic in several programs on a steady pace. ”

Join Us